ZYBERNO
Stock Report
Updated Sep 1, 2026

BLUE BIOFUELS, INC. (BIOF)

Materials • OTC

$0.11

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
0.0/100
POOR BUSINESS
BLUE BIOFUELS, INC. (BIOF) scores 0/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-202.9%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

BLUE BIOFUELS, INC. (BIOF) stock report — Zyberno Score 0/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, BIOF generated -$937.87K in Owner Earnings. Capital was deployed as follows: $68.90K invested in capital expenditures. Reinvestment rate: 2.9%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.11
Market Cap:$35.62M

Valuation Multiples (1)

Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$35.94M

Price Action & Momentum (3)

Momentum Percentile:20 / 100
% of 52-Week High:52.8%
B. Profitability Assessment

Return Metrics (4)

ROA:-226.2%
Reinvestment Rate:2.9%
Fundamental Growth Rate (g):-5.9%

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$8.25
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:42.9%
Latest Earnings Filed:2026-08-10
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.01x
Quick Ratio:0.01x
Cash Ratio:0.01x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-188.69x
Times Interest Earned:-188.69

Capital Structure (4)

Working Capital:-3,341,277.00
Cash And Cash Equivalents:22,040.00
Long Term Debt:$249.26K
Net Debt:$312.31K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$3.51M

Bottom Line Performance (3)

-$3.12M
Income Before Tax:$0.00
Ebitda Ttm:-3,404,148.00

Operating Expenses (5)

Operating Expenses:3,514,328.00
R And D Expense:2,299,274.00
Sga Expense:1,312,554.00
Income Tax Expense:$0.00
Interest Expense:19,689.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$1.32M
Current Assets:$34.09K
Ppe Net:529,719.00
Goodwill:0.00
Intangible Assets:$58.94K

Liability Structure (4)

Total Liabilities:5,379,631.00
Current Liabilities:3,375,368.00
Long Term Debt:$249.26K
Short Term Debt:$85.09K

Equity & Capital (3)

Equity:-$4.06M
Retained Earnings:-$61.54M
Common Stock:1,000,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:0.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:76,855.00
C. Cash Flow Analysis

Operating Activities (2)

-$1.28M-$1.35M

Investment Activities (2)

Investing Cash Flow:-$10.00K
Capital Expenditures Ttm:68,898.00

Financing Activities (3)

Financing Cash Flow:$372.00K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:227,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:110,180.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.01
-$0.01
Earnings Per Share Ttm:-$0.01

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$0.00

Book Value & Capital (2)

Book Value Per Share:-$0.01
Cash Per Share:0.00

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:10.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$937.87K

Damodaran Growth Analysis (2)

Reinvestment Rate:2.9%
Fundamental Growth Rate (g):-5.9%
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:BIOF
Company Name:BLUE BIOFUELS, INC.
Sector:Materials
Industry:Chemicals
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:321.22M
Shares Outstanding Basic:321.22M
Shares Outstanding Diluted:321.22M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 06:06:41 UTC
Data Timestamp:2026-08-20T16:46:17.782338
Scroll to Top